SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001571049-17-008247
Filing Date
2017-10-16
Accepted
2017-10-16 14:26:15
Documents
8

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO FORM S-1 t1702770-s1a.htm S-1/A 2054736
2 EXHIBIT 1.1 t1702770_ex1-1.htm EX-1.1 250028
3 EXHIBIT 3.10 t1702770_ex3-10.htm EX-3.10 132616
4 EXHIBIT 5.1 t1702770_ex5-1.htm EX-5.1 17810
5 EXHIBIT 10.84 t1702770_ex10-84.htm EX-10.84 137817
6 EXHIBIT 10.85 t1702770_ex10-85.htm EX-10.85 89111
7 EXHIBIT 23.1 t1702770_ex23-1.htm EX-23.1 3204
8 GRAPHIC t1702537_ex5-1img1.jpg GRAPHIC 8923
  Complete submission text file 0001571049-17-008247.txt   2698825
Mailing Address 550 SYLVAN AVENUE, SUITE 101 ENGLEWOOD CLIFFS NJ 07632
Business Address 550 SYLVAN AVENUE, SUITE 101 ENGLEWOOD CLIFFS NJ 07632 201-464-2677
IMMUNE PHARMACEUTICALS INC (Filer) CIK: 0001208261 (see all company filings)

IRS No.: 521841431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-220413 | Film No.: 171138409
SIC: 2834 Pharmaceutical Preparations